RSV – RSV – JAN Display Banners HCP Wallboard Extension – 53435

“RSV is a leading cause of morbidity and mortality worldwide in children aged under 5,” Francesca Knapper, MBBS, BSc, and colleagues wrote. “Children are predominately affected, with the greatest burden of disease in [children...

The phase 3 MATernal Immunization Study for Safety and Efficacy, or MATISSE, demonstrated that a bivalent RSV prefusion vaccine candidate successfully protected newborns against severe RSV-related respiratory illness, according...

From May 2021 through April 2022, rates of coinfection with RSV and SARS-CoV-2 were lower than expected based on rates observed with other endemic coronaviruses, according to findings published in Pediatric Pulmonology. Katia...